Skip to main content
Contact Us
Subscribe
E-Edition
44°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Prothena Corp
(NQ:
PRTA
)
14.55
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Prothena Corp
< Previous
1
2
3
4
5
6
7
8
9
Next >
Expert Ratings For Prothena Corp
November 13, 2024
Via
Benzinga
Prothena Reports Third Quarter 2024 Financial Results and Business Highlights
November 12, 2024
From
Prothena Corporation plc
Via
Business Wire
Earnings Scheduled For November 12, 2024
November 12, 2024
Via
Benzinga
Earnings Preview For Prothena Corp
November 11, 2024
Via
Benzinga
Prothena to Report Third Quarter 2024 Financial Results on November 12
November 05, 2024
From
Prothena Corporation plc
Via
Business Wire
PROCEPT BioRobotics Posts Strong Q3 Earnings, Joins Monte Rosa Therapeutics, EyePoint Pharmaceuticals And Other Big Stocks Moving Higher On Monday
October 28, 2024
Via
Benzinga
Breaking Down Prothena Corp: 4 Analysts Share Their Views
October 01, 2024
Via
Benzinga
Demystifying Prothena Corp: Insights From 8 Analyst Reviews
March 13, 2024
Via
Benzinga
Dow Dips 300 Points; Emcore Shares Spike Higher
September 30, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Monday's Intraday Session
September 30, 2024
Via
Benzinga
Crude Oil Moves Higher; Prime Medicine Shares Spike Higher
September 30, 2024
Via
Benzinga
Exposures
Fossil Fuels
Prothena Announces Leadership Team Updates
September 27, 2024
From
Prothena Corporation plc
Via
Business Wire
Decoding 6 Analyst Evaluations For Prothena Corp
February 16, 2024
Via
Benzinga
Prothena Corp: Q4 Earnings Insights
February 15, 2024
Via
Benzinga
Prothena to Participate in Upcoming Healthcare Conferences
August 29, 2024
From
Prothena Corporation plc
Via
Business Wire
PRTA Stock Earnings: Prothena Corp Beats EPS, Beats Revenue for Q2 2024
August 08, 2024
PRTA stock results show that Prothena Corp beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Prothena Reports Second Quarter 2024 Financial Results and Business Highlights
August 08, 2024
From
Prothena Corporation plc
Via
Business Wire
Prothena to Report Second Quarter 2024 Financial Results on August 8
August 01, 2024
From
Prothena Corporation plc
Via
Business Wire
Eli Lilly Drags Alzheimer's Stocks Prothena, Eisai Lower Despite FDA Win
June 11, 2024
An FDA panel unanimously backed Eli Lilly's Alzheimer's drug, but shares of Lilly and its rivals fell Tuesday.
Via
Investor's Business Daily
Exposures
Product Safety
Prothena Announces Bristol Myers Squibb Opt-in for Exclusive Global License for PRX019, the Second Program from Global Neuroscience Research and Development Collaboration
May 28, 2024
From
Prothena Corporation plc
Via
Business Wire
PRTA Stock Earnings: Prothena Corp Misses EPS, Misses Revenue for Q1 2024
May 08, 2024
PRTA stock results show that Prothena Corp missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Prothena Reports First Quarter 2024 Financial Results and Business Highlights
May 08, 2024
From
Prothena Corporation plc
Via
Business Wire
Prothena to Report First Quarter 2024 Financial Results on May 8
May 01, 2024
From
Prothena Corporation plc
Via
Business Wire
Prothena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma
April 15, 2024
From
Prothena Corporation plc
Via
Business Wire
Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback
March 28, 2024
The FDA has delayed making a decision on Eli Lilly's donanemab, pending an advisory committee meeting.
Via
Investor's Business Daily
Exposures
Product Safety
Prothena to Participate in Upcoming Healthcare Conferences
March 05, 2024
From
Prothena Corporation plc
Via
Business Wire
Prothena Appoints David Ford to Newly Created Chief People Officer Position
March 04, 2024
From
Prothena Corporation plc
Via
Business Wire
10 Health Care Stocks Whale Activity In Today's Session
February 29, 2024
Via
Benzinga
Prothena Announces Appointment of Daniel G. Welch as Director and Chair Designate
February 21, 2024
From
Prothena Corporation plc
Via
Business Wire
Prothena Reports Fourth Quarter and Full Year 2023 Financial Results, and Provides Financial Guidance and Business Highlights
February 15, 2024
From
Prothena Corporation plc
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.